CDK4 and B-cell non-Hodgkin lymphoma: Studies using a genetically modified mouse model of Eμ-myc-induced B-cell lymphoma showed that disruption of the cdk4 locus leads to genomic instability and accelerated lymphoma development via FOXO1 [178].